A novel nano-hydroxyapatite/synthetic polymer/bone morphogenetic protein-2 composite for efficient bone regeneration

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Efficient bone regeneration is crucial, but high doses of bone morphogenetic protein-2 (BMP-2) can cause side effects.
• A composite of polylactic acid-polyethene glycol (PLA-PEG) for sustained release and osteogenic nano-hydroxyapatite (nHAp) shows promise for enhancing BMP-2 efficacy.

Purpose of the Study:

• To evaluate the effectiveness of a novel PLA-PEG and nHAp composite as a carrier for BMP-2 in bone regeneration.

Main Methods:

• BMP-2 release kinetics were measured using ELISA.
• Posterolateral spinal fusion was performed on rats using three BMP-2 doses (0, 3, and 10 µg).
• Spinal fusion was assessed via micro-computed tomography (µCT), histology, and manual palpation at 8 weeks.

Main Results:

• Sustained BMP-2 release from the composite was observed up to 21 days.
• Solid spinal fusion was achieved in 91.6% of specimens in both low- and high-dose BMP-2 groups, with no fusion in the control group.
• Nano-hydroxyapatite (nHAp) was resorbed by 4 weeks, with regenerated bone forming the fusion mass by 8 weeks.

Conclusions:

• The nHAp/PLA-PEG composite facilitates efficient bone regeneration even with low-dose BMP-2.
• Sustained BMP-2 release and the osteogenic, biodegradable nature of the nHAp scaffold contribute to effective bone formation.